The results demonstrated that DM + siNC treatment didn’t change the blood glucose level, LVEF%, LVFS%, cardiac pathological changes nor IL-17 expression, as compared to DM treatment, suggesting that siNC may have little effect on the development of DCM (Supplementary Figures S4A–E). This evidence concerns the gene IL17A and familial dilated cardiomyopathy.